Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16690916rdf:typepubmed:Citationlld:pubmed
pubmed-article:16690916lifeskim:mentionsumls-concept:C0042216lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0178719lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0001721lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0150647lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0333467lld:lifeskim
pubmed-article:16690916lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:16690916pubmed:issuePt 6lld:pubmed
pubmed-article:16690916pubmed:dateCreated2006-5-12lld:pubmed
pubmed-article:16690916pubmed:abstractTextThe vaccinia virus (VACV) protein A55 is a BTB/kelch protein with a broad-complex, tramtrack and bric-a-brac (BTB) domain in the N-terminal region and five kelch repeats in the C-terminal half. The BTB/kelch subgroup of the kelch superfamily of proteins has been associated with a wide variety of functions including regulation of the cytoskeleton. VACV contains three genes predicted to encode BTB/kelch proteins: A55R, F3L and C2L. The A55R gene product has been identified as an intracellular protein of 64 kDa that is expressed late in infection. A VACV strain lacking 93.6% of the A55R open reading frame (vdeltaA55) was constructed and found to have an unaltered growth rate in vivo but a different plaque morphology and cytopathic effect, as well as reduced development of VACV-induced Ca2+-independent cell/extracellular matrix adhesion. In a murine intradermal model of VACV infection, a virus lacking the A55R gene induced larger lesions than wild-type and revertant control viruses.lld:pubmed
pubmed-article:16690916pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690916pubmed:languageenglld:pubmed
pubmed-article:16690916pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690916pubmed:citationSubsetIMlld:pubmed
pubmed-article:16690916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690916pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690916pubmed:statusMEDLINElld:pubmed
pubmed-article:16690916pubmed:monthJunlld:pubmed
pubmed-article:16690916pubmed:issn0022-1317lld:pubmed
pubmed-article:16690916pubmed:authorpubmed-author:SmithGeoffrey...lld:pubmed
pubmed-article:16690916pubmed:authorpubmed-author:BeardPhilippa...lld:pubmed
pubmed-article:16690916pubmed:authorpubmed-author:FroggattGraha...lld:pubmed
pubmed-article:16690916pubmed:issnTypePrintlld:pubmed
pubmed-article:16690916pubmed:volume87lld:pubmed
pubmed-article:16690916pubmed:ownerNLMlld:pubmed
pubmed-article:16690916pubmed:authorsCompleteYlld:pubmed
pubmed-article:16690916pubmed:pagination1521-9lld:pubmed
pubmed-article:16690916pubmed:dateRevised2007-8-13lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:meshHeadingpubmed-meshheading:16690916...lld:pubmed
pubmed-article:16690916pubmed:year2006lld:pubmed
pubmed-article:16690916pubmed:articleTitleVaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model.lld:pubmed
pubmed-article:16690916pubmed:affiliationDepartment of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.lld:pubmed
pubmed-article:16690916pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16690916pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16690916lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16690916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16690916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16690916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16690916lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16690916lld:pubmed